Cite

HARVARD Citation

    Jiang, A. et al. (2022). CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types. Oxidative medicine and cellular longevity. p. . [Online]. 
  
Back to record